Despite decades of research and clinic progress, including innovations in antibody-based medicines, many patients continue to suffer due to a lack of good treatment options. Vast aspects of the mechanisms driving their disease are often inaccessible to current therapeutics. When treatments do exist, they can be toxic.
Attovia aims to change this.
By utilizing our ATTOBODY® technology, we will develop medicines that target unaddressed elements of disease, as well as offer better efficacy and tolerability. We will bring treatments to patients where none exist and create best-in-class options where current solutions fall short.
We envision a world where no patient is left behind.